Evidence map›Paper›PMID 29891597›Full record

ArticleAntimicrobial agents and chemotherapy2018

Emergence of Azole-Resistant Aspergillus fumigatus from Immunocompromised Hosts in India.

Yubhisha Dabas, Immaculata Xess, Sameer Bakshi, Manoranjan Mahapatra, Rachna Seth

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Azole-ResistantJournal of fungi (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Invasive Fungal Infections 2021.Journal of fungi (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Prognostic Scores and Azole-ResistantJournal of fungi (Basel, Switzerland) · 2021
    Article
  9. Studies in mycology · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yubhisha DabasDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Immaculata XessDepartment of Microbiology, All India Institute of Medical Sciences, New Delhi, India immaculataxess@gmail.com.ORCID 0000-0002-1018-6617
Sameer BakshiDepartment of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
Manoranjan MahapatraDepartment of Hematology, All India Institute of Medical Sciences, New Delhi, India.
Rachna SethDepartment of Paediatrics, All India Institute of Medical Sciences, New Delhi, India.
All India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This prospective study shows that the rate of azole-resistant

Indexed as

AdolescentAspergillus fumigatusAzolesChildDrug Resistance, FungalFemaleFungal ProteinsHumansImmunocompromised HostIndiaMaleMicrobial Sensitivity TestsMiddle AgedMutationProspective StudiesVoriconazoleAzolesFungal ProteinsVoriconazoleantifungal susceptibility testingazole-resistant Aspergillus fumigatuscyp51A mutationsimmunocompromised hostsIndiainvasive aspergillosisrisk factor

Identifiers

PMID29891597
PMCPMC6105863
OpenAlexW2805925446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.